secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001609550-26-000026
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical shareholders approve declassification, 2.6M-share increase to equity plan
--------------------------------------------------------------------------------

- Stockholders approved phasing out classified board; all directors to be elected annually starting 2029.
- Approved amendment of 2018 Incentive Award Plan: adds 2.6M shares (total authorized 9.9M), removes evergreen, extends term to 2036.
- Elected Class II directors: Ellis, Melenikiotou, Mead Jr. with >17M votes for each.
- Ratified Ernst & Young as auditor (25.1M for); approved say-on-pay (22.5M for) with 1-year frequency (22.9M for).
- Proposal 5 (declassification) passed with 23.1M for; Proposal 6 (equity plan) passed with 14.3M for; broker non-votes not counted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000026/0001609550-26-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000026/insp-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001609550-26-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer